Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3Cardiotoxicity 2Breast Neoplasms 2Weight Gain 1Renal Insufficiency, Chronic 1Neoplasms 1Kidney Neoplasms 1Heart Failure 1Diabetes Mellitus, Type 2 1Carcinoma, Renal Cell 1

Interventions

Metformin 2empagliflozin 1Weights and Measures 1Tablets 1Sucrose 1Secondary Prevention 1Exercise 1Diet Therapy 1Cognitive Behavioral Therapy 1Aspartame 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Weight Gain × empagliflozin × Clear all
NCT06140108 2025-05-14

Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity

SINA Health Education and Welfare Trust

Phase 2/3 Completed
70 enrolled

Polycystic Ovary Syndrome, Weight Gain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡